Bernard Coulie, President and CEO at PLIANT THERAPEUTICS, INC. (PLRX), sold 60,000 shares at $34.08 ($2.0M) on 2023-02-03, disclosed to the SEC on 2023-02-06.
Open-market sale of $2.0M PLRX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.13 | 13,395 | $457K | 22.5% |
| 2 | $34.13 | 13,395 | $457K | 22.5% |
| 3 | $34.96 | 1,605 | $56K | 2.8% |
| 4 | $34.96 | 1,605 | $56K | 2.8% |
| 5 | $33.36 | 9,738 | $325K | 16.0% |
| 6 | $33.36 | 9,738 |
| $325K |
| 16.0% |
| 7 | $34.08 | 5,262 | $179K | 8.8% |
| 8 | $34.08 | 5,262 | $179K | 8.8% |
| Total | $33.92 avg | 60,000 | $2.0M | 100% |
| Filing → |
| PLRX | SELL | 2024-07-12 | $895K | — | Filing → |
| PLRX | SELL | 2024-01-19 | $886K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $2.5M | — | Filing → |